These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
1-10185
|
26-1331503
|
|
(State or Other Jurisdiction
|
(Commission
|
(I.R.S. Employer
|
|
of Incorporation)
|
File Number)
|
Identification No.)
|
|
Large accelerated
filer
|
☐
|
|
Accelerated
filer
|
☐
|
|
|
Non-accelerated
filer
|
☐
|
|
Smaller reporting
company
|
☑
|
|
|
2
|
||
|
|
2
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
5
|
|
|
|
6
|
|
|
12
|
||
|
19
|
||
|
19
|
||
|
|
||
|
20
|
||
|
20
|
||
|
20
|
||
|
20
|
||
|
20
|
||
|
20
|
||
|
20
|
||
|
21
|
||
|
|
September
30,
|
December 31,
|
|
|
2016
|
2015
|
|
ASSETS
|
(unaudited)
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
5,135,430
|
$
4,215,145
|
|
Accounts receivable
(net of allowance for doubtful accounts of $474,806 and $396,884,
respectively)
|
1,323,109
|
1,253,628
|
|
Other current
assets
|
386,110
|
252,468
|
|
Total current
assets
|
6,844,649
|
5,721,241
|
|
Capitalized
software (net of accumulated amortization of $155,406 and $25,133,
respectively)
|
1,696,871
|
723,962
|
|
Fixed assets (net
of accumulated depreciation of $302,214 and $262,797,
respectively)
|
170,995
|
175,497
|
|
Deferred income tax
asset - noncurrent
|
-
|
97,974
|
|
Other long-term
assets
|
18,253
|
18,301
|
|
Goodwill
|
2,241,872
|
2,241,872
|
|
Intangible assets
(net of accumulated amortization of $3,219,125 and $2,512,704,
respectively)
|
1,484,875
|
2,191,296
|
|
Total
assets
|
$
12,457,515
|
$
11,170,143
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts
payable
|
$
288,488
|
$
385,285
|
|
Accrued
expenses
|
687,835
|
995,999
|
|
Income taxes
payable
|
195,164
|
199,613
|
|
Deferred
revenue
|
940,065
|
822,481
|
|
Total current
liabilities
|
2,111,552
|
2,403,378
|
|
Deferred income tax
liability
|
211,124
|
94,566
|
|
Other long-term
liabilities
|
120,438
|
113,222
|
|
Total
liabilities
|
2,443,114
|
2,611,166
|
|
Commitments and
contingencies
|
|
|
|
Stockholders'
equity:
|
|
|
|
Preferred stock,
$0.001 par value, 30,000,000 shares authorized, no shares issued
and outstanding as of September 30, 2016 and December 31,
2015.
|
-
|
-
|
|
Common stock $0.001
par value, 100,000,000 shares authorized, 2,847,444 and 2,785,044
shares issued and outstanding as of September 30, 2016 and December
31, 2015, respectively.
|
2,847
|
2,785
|
|
Additional paid-in
capital
|
8,912,428
|
8,202,605
|
|
Other accumulated
comprehensive loss
|
(24,693
)
|
(35,154
)
|
|
Retained
earnings
|
1,123,819
|
388,741
|
|
Total stockholders' equity
|
10,014,401
|
8,558,977
|
|
Total
liabilities and stockholders’ equity
|
$
12,457,515
|
$
11,170,143
|
|
|
For the three
months ended
|
For the nine months
ended
|
||
|
|
September
30,
2016
|
September
30,
2015
|
September
30,
2016
|
September
30,
2015
|
|
Revenues
|
$
2,872,983
|
$
2,787,105
|
$
9,284,346
|
$
8,937,276
|
|
Cost of
services
|
739,431
|
843,007
|
2,333,234
|
2,655,425
|
|
Gross
profit
|
2,133,552
|
1,944,098
|
6,951,112
|
6,281,851
|
|
Operating costs and
expenses:
|
|
|
|
|
|
General and
administrative
|
839,364
|
759,843
|
2,481,620
|
2,546,966
|
|
Sales and
marketing
|
651,606
|
519,826
|
1,947,305
|
1,730,446
|
|
Product
development
|
132,627
|
63,297
|
291,519
|
256,393
|
|
Depreciation and
amortization
|
215,666
|
268,775
|
779,813
|
800,515
|
|
Total operating
costs and expenses
|
1,839,263
|
1,611,741
|
5,500,257
|
5,334,320
|
|
Operating
income
|
294,289
|
332,357
|
1,450,855
|
947,531
|
|
Other income
(expense):
|
|
|
|
|
|
Other income
(expense), net
|
(7,418
)
|
-
|
74,634
|
-
|
|
Interest income
(expense), net
|
1,036
|
(137,150
)
|
2,993
|
(623,025
)
|
|
Total other income
(expense)
|
(6,382
)
|
(137,150
)
|
77,627
|
(623,025
)
|
|
Income before
taxes
|
287,907
|
195,207
|
1,528,482
|
324,506
|
|
Income
tax benefit (expense)
|
(93,029
)
|
(58,477
)
|
(483,677
)
|
113,917
|
|
Net
income
|
$
194,878
|
$
136,730
|
$
1,044,805
|
$
438,423
|
|
Income per share
– basic
|
$
0.07
|
$
0.05
|
$
0.37
|
$
0.18
|
|
Income per share -
fully diluted
|
$
0.07
|
$
0.05
|
$
0.36
|
$
0.18
|
|
Weighted average
number of common shares outstanding - basic
|
2,836,066
|
2,515,767
|
2,806,566
|
2,390,524
|
|
Weighted average
number of common shares outstanding - fully
diluted
|
2,936,149
|
2,552,586
|
2,898,973
|
2,427,886
|
|
|
For the three
months ended
|
For the nine months
ended
|
||
|
|
September
30,
2016
|
September
30,
2015
|
September
30,
2016
|
September
30,
2015
|
|
Net
income
|
$
194,878
|
$
136,730
|
$
1,044,805
|
$
438,423
|
|
Foreign
currency translation adjustment
|
(2,146
)
|
5,709
|
10,461
|
7,087
|
|
Comprehensive
income
|
$
192,732
|
$
142,439
|
$
1,055,266
|
$
445,510
|
|
|
Nine months
ended
September
30,
|
|
|
|
2016
|
2015
|
|
Cash
flows from operating activities:
|
|
|
|
Net
income
|
$
1,044,805
|
$
438,423
|
|
Adjustments to
reconcile net income to net cash
|
|
|
|
provided
by operating activities:
|
|
|
|
Depreciation
and amortization
|
899,928
|
800,515
|
|
Bad
debt expense
|
190,690
|
136,339
|
|
Deferred
income taxes
|
72,564
|
(106,571
)
|
|
Stock-based
compensation expense
|
460,148
|
418,865
|
|
Non-cash
interest expense
|
-
|
535,397
|
|
Changes in
operating assets and liabilities:
|
|
|
|
Decrease
(increase) in accounts receivable
|
(273,557
)
|
421,412
|
|
Decrease
(increase) in other assets
|
(134,564
)
|
(295,643
)
|
|
Increase
(decrease) in accounts payable
|
(94,946
)
|
122,481
|
|
Increase
(decrease) in accrued expenses
|
(281,322
)
|
(168,497
)
|
|
Increase
(decrease) in deferred revenue
|
136,103
|
8,474
|
|
Net cash provided
by operating activities
|
2,019,849
|
2,311,195
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
Capitalized
software
|
(750,938
)
|
(337,401
)
|
|
Purchase of fixed
assets
|
(58,732
)
|
(45,306
)
|
|
Net cash used in
investing activities
|
(809,670
)
|
(382,707
)
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
Proceeds from
exercise of stock options, net of income taxes
|
33,294
|
21,075
|
|
Tax benefit on
stock-based compensation awards
|
-
|
18,709
|
|
Payment of
dividend
|
(309,727
)
|
-
|
|
Net cash provided
by (used in) financing activities
|
(276,433
)
|
39,784
|
|
|
|
|
|
Net change in Cash
|
933,746
|
1,968,272
|
|
Cash –
beginning
|
4,215,145
|
1,721,343
|
|
Currency
translation adjustment
|
(13,461
)
|
1,965
|
|
Cash –
ending
|
$
5,135,430
|
$
3,691,580
|
|
Supplemental
disclosure for non-cash investing and financing
activities
|
|
|
|
Cash
paid for interest
|
$
-
|
$
85,870
|
|
Cash
paid for income taxes
|
$
434,595
|
$
265,851
|
|
Non cash
activities
|
|
|
|
Stock-based
compensation - capitalized software
|
$
352,244
|
$
188,144
|
|
Conversion of note payable to common stock
|
$
-
|
$
1,666,673
|
|
|
Options
Outstanding
|
Options
Exercisable
|
||
|
Exercise Price
Range
|
Number
|
Weighted Average
Remaining Contractual Life (in Years)
|
Weighted Average
Exercise Price
|
Number
|
|
$
0.01 - $1.00
|
12,850
|
5.31
|
$
0.01
|
12,850
|
|
$
1.01 - $3.00
|
1,000
|
4.65
|
$
1.70
|
1,000
|
|
$
3.01 - $4.00
|
11,000
|
5.50
|
$
3.33
|
11,000
|
|
$
4.01 - $8.00
|
102,500
|
4.86
|
$
7.67
|
72,500
|
|
$
8.01 - $9.00
|
30,000
|
1.89
|
$
8.25
|
30,000
|
|
$
9.01 - $10.00
|
11,917
|
8.24
|
$
9.26
|
6,167
|
|
$
10.01 - $13.49
|
40,000
|
2.44
|
$
13.49
|
25,000
|
|
Total
|
209,267
|
4.23
|
$
8.23
|
158,517
|
|
|
Three months
ended
|
Nine months
ended
|
||
|
|
September
30,
|
September
30,
|
||
|
Revenue Streams
|
2016
|
2015
|
2016
|
2015
|
|
Disclosure
management
|
20.5
%
|
20.8
%
|
19.6
%
|
22.3
%
|
|
Shareholder
communications
|
62.1
%
|
69.7
%
|
63.6
%
|
68.6
%
|
|
Platform &
technology
|
17.4
%
|
9.5
%
|
16.8
%
|
9.1
%
|
|
Total
|
100.0
%
|
100.0
%
|
100.0
%
|
100.0
%
|
|
|
Three
months ended
|
Nine
months ended
|
||
|
|
September
30,
|
September
30,
|
||
|
Geographic Region
|
2016
|
2015
|
2016
|
2015
|
|
North
America
|
$
2,508,532
|
$
2,293,272
|
$
8,057,020
|
$
7,331,427
|
|
Europe
|
364,451
|
493,833
|
1,227,326
|
1,605,849
|
|
Total
|
$
2,872,983
|
$
2,787,105
|
9,284,346
|
$
8,937,276
|
|
|
Three months
ended
|
Nine months
ended
|
||
|
|
September
30,
|
September
30,
|
||
|
Revenue Streams
|
2016
|
2015
|
2016
|
2015
|
|
Disclosure
management
|
|
|
|
|
|
Revenue
|
$
588,964
|
$
579,845
|
$
1,820,106
|
$
1,993,258
|
|
Gross
Margin
|
$
390,212
|
$
405,035
|
$
1,259,929
|
$
1,413,793
|
|
Gross
Margin %
|
66
%
|
70
%
|
69
%
|
71
%
|
|
|
|
|
|
|
|
Shareholder
communications
|
|
|
|
|
|
Revenue
|
$
1,782,963
|
$
1,941,792
|
$
5,902,042
|
$
6,131,529
|
|
Gross
Margin
|
$
1,334,023
|
$
1,318,173
|
$
4,390,147
|
$
4,196,560
|
|
Gross
Margin %
|
75
%
|
68
%
|
74
%
|
68
%
|
|
|
|
|
|
|
|
Platform
& technology
|
|
|
|
|
|
Revenue
|
$
501,056
|
$
265,468
|
$
1,562,198
|
$
812,489
|
|
Gross
Margin
|
$
409,317
|
$
220,890
|
$
1,301,036
|
$
671,498
|
|
Gross
Margin %
|
82
%
|
83
%
|
83
%
|
83
%
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
Revenue
|
$
2,872,983
|
$
2,787,105
|
$
9,284,346
|
$
8,937,276
|
|
Gross
Margin
|
$
2,133,552
|
$
1,944,098
|
$
6,951,112
|
$
6,281,851
|
|
Gross
Margin %
|
74
%
|
70
%
|
75
%
|
70
%
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
|
|
|
Certification of
Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.*
|
|
|
|
|
Certification of
Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.*
|
|
|
|
|
Certification of
Chief Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.*
|
|
|
|
|
Certification of
Chief Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.*
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance
Document.**
|
|
|
101.SCH
|
|
XBRL Taxonomy
Extension Schema Document.**
|
|
|
101.CAL
|
|
XBRL Taxonomy
Calculation Linkbase Document.**
|
|
|
101.LAB
|
|
XBRL Taxonomy Label
Linkbase Document.**
|
|
|
101.PRE
|
|
XBRL Taxonomy
Presentation Linkbase Document.**
|
|
|
101.DEF
|
|
XBRL Taxonomy
Extension Definition Linkbase Document. **
|
|
*
|
filed or furnished
herewith
|
|
**
|
submitted
electronically herewith
|
|
|
ISSUER
DIRECT CORPORATION
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Brian R.
Balbirnie
|
|
|
|
|
Brian R.
Balbirnie
|
|
|
|
|
Chief Executive
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Steven
Knerr
|
|
|
|
|
Steven
Knerr
|
|
|
|
|
Chief Financial
Officer
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|